ZyVersa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (ZVSA)
Historical Holders from Q2 2024 to Q3 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Symbol
-
ZVSA on OTC
-
Shares outstanding
-
8,352,705
-
Price per share
-
$0.14
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
7
-
Total reported value
-
$1
-
% of total 13F portfolios
-
0%
-
Share change
-
-66,061
-
Value change
-
-$44,731
-
Number of holders
-
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of ZyVersa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (ZVSA) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
ARMISTICE CAPITAL, LLC
|
5%
|
-50%
|
$58,352
|
+$18,447
|
416,800
|
+46%
|
Armistice Capital, LLC
|
30 Jun 2025
|
As of 30 Sep 2025,
ZyVersa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (ZVSA) has
1
institutional shareholder
filing 13F forms.
They hold
7 shares.
of 8,352,705
outstanding shares (0%)
.
Institutional Holders of ZyVersa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (ZVSA) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
7
|
$1
|
-$44,731
|
|
|
$0.14
|
1
|
|
2025 Q2
|
66,068
|
$44,732
|
-$1,713
|
|
|
$0.68
|
6
|
|
2025 Q1
|
69,877
|
$43,919
|
-$27,735
|
|
|
$0.63
|
7
|
|
2024 Q4
|
81,085
|
$86,175
|
+$82,931
|
|
|
$1.06
|
8
|
|
2024 Q3
|
3,009
|
$7,220
|
-$30,565
|
|
|
$2.38
|
5
|
|
2024 Q2
|
10,305
|
$38,746
|
+$38,746
|
|
|
$3.76
|
4
|